Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02332161 · ClinicalTrials.gov registry record
Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 8
- Enrollment target
NCT02332161: Completed study, sponsored by University of Chicago.
NCT02332161 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02332161 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Anterolateral thigh (ALT) free flap tissue transfer is a commonly used method of head and neck reconstruction after head and neck cancer removal. The procedure involves removing some muscle, skin, and tissue from the thigh, and this may affect leg function. The purpose of this study is to determine the impact of ALT on ambulation and activities of daily living (ADLs)
Primary Outcome
The Lower Extremity Functional Scale (LEFS) is a validated self-report measure designed to assess the functional capabilities of patients with any lower extremity related musculoskeletal condition. Subjects will be assessed for a change from pre- to post-operative
Interventions
- OTHER surveys, evaluative tests for leg function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-06-26 |
What the finished NCT02332161 record still lists
NCT02332161 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which surveys, evaluative tests for leg function is the first listed.
NCT02332161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02332161 about?
NCT02332161 is a clinical study titled "Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer". Anterolateral thigh (ALT) free flap tissue transfer is a commonly used method of head and neck reconstruction after head and neck cancer removal. The procedure involves removing some muscle, skin, and tissue from the thigh, and this may affect leg function. The purpose of this study is to determine ...
What is the current status of trial NCT02332161?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2014-01. Estimated completion is 2017-06-26.
What interventions are being tested in trial NCT02332161?
The interventions under investigation include: surveys, evaluative tests for leg function (OTHER).
Who is sponsoring clinical trial NCT02332161?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia